Tildrakizumab-asmn Subcutaneous and Vanacof-8
Determining the interaction of Tildrakizumab-asmn Subcutaneous and Vanacof-8 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Tildrakizumab
Generic Name: chlophedianol / pyrilamine
Brand name: Ninjacof, Vanacof-8
Synonyms: Chlophedianol and Pyrilamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Tildrakizumab-asmn Subcutaneous-Vanadom
- Tildrakizumab-asmn Subcutaneous-Vanahist PD
- Tildrakizumab-asmn Subcutaneous-Vanamine PD
- Tildrakizumab-asmn Subcutaneous-Vanatab DX
- Tildrakizumab-asmn Subcutaneous-Vanatol LQ
- Tildrakizumab-asmn Subcutaneous-Vanatol S
- Vanacof-8-Tilia Fe
- Vanacof-8-Tiludronate
- Vanacof-8-Timentin
- Vanacof-8-Timentin Add-Vantage
- Vanacof-8-Timentin Injection
- Vanacof-8-Timentin Novaplus